Temasek leads Tropic Biosciences' US$28.5m Series B funding round
Singapore
BIOTECH startup Tropic Biosciences, which develops high-performance varieties of tropical crops, on Thursday said it has raised US$28.5 million in a Series B round of funding led by Singapore investment firm Temasek Holdings, bringing its total equity funding raised to US$40 million.
The equity round is joined by new investors including Sumitomo Corporation Europe,…
A NEWSLETTER FOR YOU
Garage
The hottest news on all things startup and tech to kickstart your week.
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Companies & Markets
GM CEO Barra compensation fell 4% in 2023 to US$27.8 million
Prada’s sales up 16% in first quarter as Miu Miu shines
Boeing reports first revenue drop in 7 quarters as deliveries decline
OUE Reit Q1 NPI rises 6.9% to S$60.5 million
OKP unit gets S$92.9 million LTA contract
Greenback recovers from PMI slump, yen closes in on 155 per dollar